Literature DB >> 29302108

Developments in small animal veterinary dermatology.

Kinga Gortel1.   

Abstract

Mesh：

Year:  2018        PMID： 29302108      PMCID： PMC5731399     

Source DB:  PubMed          Journal:  Can Vet J        ISSN： 0008-5286            Impact factor:   1.008


× No keyword cloud information.
  25 in total

1.  The use of oral fluralaner for the treatment of feline generalised demodicosis: a case report.

Authors:  I Matricoti; E Maina
Journal:  J Small Anim Pract       Date:  2017-05-03       Impact factor: 1.522

2.  Prevalence of methicillin-resistant staphylococci in canine pyoderma cases in primary care veterinary practices in Canada: A preliminary study.

Authors:  Daniel Joffe; Fiona Goulding; Ken Langelier; Gabor Magyar; Les McCurdy; Moe Milstein; Kia Nielsen; Stephanie Villemaire
Journal:  Can Vet J       Date:  2015-10       Impact factor: 1.008

3.  A blinded, randomized, placebo-controlled, dose determination trial of lokivetmab (ZTS-00103289), a caninized, anti-canine IL-31 monoclonal antibody in client owned dogs with atopic dermatitis.

Authors:  Gina M Michels; Deborah S Ramsey; Kelly F Walsh; Olivier M Martinon; Sean P Mahabir; Jacquelien D Hoevers; Rodney R Walters; Steven A Dunham
Journal:  Vet Dermatol       Date:  2016-09-19       Impact factor: 1.589

4.  A blinded, randomized clinical trial evaluating the efficacy and safety of lokivetmab compared to ciclosporin in client-owned dogs with atopic dermatitis.

Authors:  Hilde Moyaert; Leen Van Brussel; Stasia Borowski; Monica Escalada; Sean P Mahabir; Rodney R Walters; Michael R Stegemann
Journal:  Vet Dermatol       Date:  2017-09-14       Impact factor: 1.589

5.  Efficacy of sarolaner, a novel oral isoxazoline, against two common mite infestations in dogs: Demodex spp. and Otodectes cynotis.

Authors:  Robert H Six; Csilla Becskei; Mark M Mazaleski; Josephus J Fourie; Sean P Mahabir; Melanie R Myers; Nathalie Slootmans
Journal:  Vet Parasitol       Date:  2016-03-04       Impact factor: 2.738

6.  Efficacy of proactive long-term maintenance therapy of canine atopic dermatitis with 0.0584% hydrocortisone aceponate spray: a double-blind placebo controlled pilot study.

Authors:  Ana M Lourenço; Vanessa Schmidt; Berta São Braz; Diana Nóbrega; Telmo Nunes; José H Duarte-Correia; Daniela Matias; Emi Maruhashi; Christophe A Rème; Tim Nuttall
Journal:  Vet Dermatol       Date:  2016-01-25       Impact factor: 1.589

Review 7.  Life-long diseases need life-long treatment: long-term safety of ciclosporin in canine atopic dermatitis.

Authors:  Tim Nuttall; Douglas Reece; Elizabeth Roberts
Journal:  Vet Rec       Date:  2014-03       Impact factor: 2.695

8.  A blinded, randomized clinical trial comparing the efficacy and safety of oclacitinib and ciclosporin for the control of atopic dermatitis in client-owned dogs.

Authors:  Peter R Little; Vickie L King; Kylie R Davis; Sallie B Cosgrove; Michael R Stegemann
Journal:  Vet Dermatol       Date:  2014-12-12       Impact factor: 1.589

9.  Efficacy of afoxolaner in a clinical field study in dogs naturally infested with Sarcoptes scabiei.

Authors:  Frédéric Beugnet; Christa de Vos; Julian Liebenberg; Lénaïg Halos; Diane Larsen; Josephus Fourie
Journal:  Parasite       Date:  2016-06-17       Impact factor: 3.000

10.  Critically appraised topic on adverse food reactions of companion animals (4): can we diagnose adverse food reactions in dogs and cats with in vivo or in vitro tests?

Authors:  Ralf S Mueller; Thierry Olivry
Journal:  BMC Vet Res       Date:  2017-08-30       Impact factor: 2.741
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.